Filing metadata

Accession number
0001641172-25-007758
Form type
Form 3
Filer
Kairos Pharma, LTD.
CIK
CIK 1962011
Filed
Apr 30, 2025
Reporting period
Dec 10, 2024
Description
Initial ownership

Explore SEC Filings Hub

3 | SEC Filings Hub